Login / Signup

Anti-Angiogenic Activity Of Bevacizumab-Bearing Dexamethasone-Loaded PLGA Nanoparticles For Potential Intravitreal Applications.

Jiaxin LiuXueyan ZhangGe LiFei XuShuang LiLesheng TengYouxin LiFengying Sun
Published in: International journal of nanomedicine (2019)
The eBev-DPPNs are a promising novel anti-angiogenesis therapeutic for potential intravitreal applications such as age-related macular degeneration.
Keyphrases
  • age related macular degeneration
  • vascular endothelial growth factor
  • drug delivery
  • endothelial cells
  • diabetic retinopathy
  • low dose
  • human health
  • high dose
  • cancer therapy
  • drug release